Is elevation of the serum β-d-glucan level a paradoxical sign for Trichosporon fungemia in patients with hematologic disorders?

International Journal of Infectious Diseases

Volumn 16, Issue 1, 2012, Pages e2-

  Nakase, Kazunori ^a,b   Suzuki, Kei ^b   Kyo, Taiichi ^c   Kohara, Tadahiro ^c   Sugawara, Yumiko ^b   Katayama, Naoyuki ^b  

^a MIE UNIVERSITY HOSPITAL   (Japan)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

Author keywords

1,3 d glucan; Hematologic disorder; Trichosporon fungemia

Indexed keywords

1,3 BETA D GLUCAN; AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; BETA GLUCAN; BETA LACTAM ANTIBIOTIC; FLUCONAZOLE; GLYCOPEPTIDE; ITRACONAZOLE; MICAFUNGIN; MICONAZOLE; PIPERACILLIN PLUS TAZOBACTAM; PYRROLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIMICROBIAL THERAPY; APLASTIC ANEMIA; BLOOD LEVEL; CHRONIC MYELOID LEUKEMIA; FEMALE; FEVER; FUNGEMIA; HEMATOLOGIC DISEASE; HEMODIALYSIS; HUMAN; HYPERGLYCEMIA; INFECTION PREVENTION; MACROGLOBULINEMIA; MALE; NONHODGKIN LYMPHOMA; SHORT SURVEY; TRICHOSPORON;

EID: 84855297793     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2011.09.017     Document Type: Short Survey

References (23)

1. Obayashi T., Yoshida M., Mori M., Goto H., Yasuoka A., Iwasaki H. Plasma (1→3)-beta-d-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995, 345:17-20.
2. Koo S., Bryar J.M., Page J.H., Baden L.R., Marty F.M. Diagnostic performance of the (1→3)-beta-d-glucan assay for invasive fungal disease. Clin Infect Dis 2009, 49:1650-1659.
3. Karageorgopoulos D.E., Vouloumanou E.K., Ntziora F., Michalopoulos A., Rafailidis P.I., Falagas M.E. β-d-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis 2011, 52:750-770.
4. Walsh T.J. Trichosporonosis. Infect Dis Clin North Am 1989, 3:43-52.
5. Girmenia C., Pagano L., Martino B., D'Antonio D., Fanci R., Specchia G., et al. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J Clin Microbiol 2005, 43:1818-1828.
6. Suzuki K., Nakase K., Kyo T., Kohara T., Sugawara Y., Shibazaki T., et al. Fatal Trichosporon fungemia in patients with hematologic malignancies. Eur J Haematol 2010, 84:441-447.
7. Matsue K., Uryu H., Koseki M., Asada N., Takeuchi M. Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin. Clin Infect Dis 2004, 42:753-757.
8. Ellis M., Al-Ramadi B., Finkelman M., Hedstrom U., Kristensen J., Ali-Zadeh H., et al. Assessment of the clinical utility of serial β-d-glucan concentrations in patients with persistent neutropenic fever. J Med Microbiol 2008, 57:287-295.
9. Albert O., Toubas D., Strady C., Cousson J., Delmas C., Vernet V., et al. Reactivity of (1→3)-β-d-glucan assay in bacterial bloodstream infections. Eur J Clin Microbiol Infect Dis 2011, 30:1453-1460.
10. Kato A., Takita T., Furuhashi M., Takahashi T., Maruyama Y., Hishida A. Elevation of blood (1→3)-beta-d-glucan concentration in hemodialysis patients. Nephron 2001, 89:15-19.
11. Usami M., Ohta A., Horiuchi T., Nagasawa K., Wakabayashi T., Tanaka S. Positive (1→3)-beta-d-glucan in blood components and release of (1→3)-beta-d-glucan from depth-type membrane filters for blood processing. Transfusion 2002, 42:1189-1195.
12. Marty F.M., Lowry C.M., Lempitski S.J., Kubiak D.W., Finkelman M.A., Baden L.R. Reactivity of (1→3)-beta-d-glucan assay with commonly used intravenous antimicrobials. Antimicrob Agents Chemother 2006, 50:3450-3453.
13. Nakao A., Yasui M., Kawagoe T., Tamura H., Tanaka S., Takagi H. False-positive endotoxemia derives from gauze glucan after hepatectomy for hepatocellular carcinoma with cirrhosis. Hepatogastroenterology 1997, 44:1413-1418.
14. Chandrasekar P.H., Sobel J.D. Micafungin: a new echinocandin. Clin Infect Dis 2006, 42:1171-1178.
15. Anaissie E., Gokaslan A., Hachem R., Rubin R., Griffin G., Robinson R. Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review. Clin Infect Dis 1992, 15:781-787.
16. Fournier S., Pavageau W., Feuillhade M., Deplus S., Zagdanski A.M., Verola O. Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukemia. Eur J Clin Microbiol Infect Dis 2002, 21:892-896.
17. Wiederhold N.P., Najvar L.K., Vallor A.C., Kirkpatrick W.R., Bocanegra R., Molina D. Assessment of serum (1→3)-β-d-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis. Antimicrob Agents Chemother 2008, 52:1176-1178.
18. Goodridge H.S., Wolf A.J., Underhill D.M. Beta-glucan recognition by the innate immune system. Immunol Rev 2009, 230:38-50.
19. Brown G.D., Gordon S. Fungal β-glucans and mammalian immunity. Immunity 2003, 19:311-315.
20. Cramer D.E., Allendorf D.J., Baran J.T., Hansen R., Marroquin J., Li B., et al. Beta-glucan enhances complement-mediated hematopoietic recovery after bone marrow-injury. Blood 2006, 107:835-840.
21. Golde D.W., Finley T.N., Cline M.J. The pulmonary macrophage in acute leukemia. N Engl J Med 1974, 290:875-878.
22. Nakase K., Tsuji K., Miyanishi E., Shirakawa S. Pathogenesis of fever of unknown origin in patients with acute leukemia and granulocytopenia. Med Hypotheses 1990, 33:235-237.
23. Tzianabos A.O. Polysaccharide immunomodulators as therapeutic agents: structural aspects and biologic function. Clin Microbiol Rev 2000, 13:523-533.